OTC Diagnostics Forecast: Growing With Pandemic But High Bar For Approval Could Slow Spread
Executive Summary
Sample-collection kit and testing firms acknowledge regulatory approval for OTC sales can be as complicated as the technology behind their products. But consumers have OTC access to numerous at-home collection kits for tests for indications of diseases or medical conditions as well as for genealogy. Kits approved for testing for influenzas or other infections also should become available OTC, say industry stakeholders.
You may also be interested in...
Expected Spread Of US OTC Diagnostics Could Change Consumers’ Health Care Behaviors
Diagnostics platform provider Ash Wellness expects at-home test providers can help improve consumers’ long-term health care outcomes with follow-up and ongoing communications for users of their products, influencing them to change behaviors.
Expected Spread Of US OTC Diagnostics Could Change Consumers’ Health Care Behaviors
Diagnostics platform provider Ash Wellness expects at-home test providers can help improve consumers’ long-term health care outcomes with follow-up and ongoing communications for users of their products, influencing them to change behaviors.
US Market For OTC COVID-19 Tests Transitions From Unmet Demand To Multiple Choices
Abbott’s’s distribution of its BinaxNOW COVID-19 Ag Self Test to US retailers increases to three the number of OTC tests for the virus that CVS offers, along with Ellume’s and Labcorp’s test kits also available under EUAs granted by FDA.